Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists | Pharmacology
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective | Pharmacology
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
κ-opioid receptor - Wikiwand
Medicinal Chemistry of Kappa Opioid Receptor Antagonists | SpringerLink
Antagonists of the kappa opioid receptor - ScienceDirect
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Opioid receptor subtypes: fact or artifact? - British Journal of Anaesthesia
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Peripherally acting u-opioid receptor antagonists as treatment opti | PPA
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Mu Opioid Receptor Antagonists: Recent Developments - Goodman - 2007 - ChemMedChem - Wiley Online Library
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Kappa Opioid System in Nucleus Accumbens Drives Pain-Induced Negative Affect | Pain Research Forum
nor-Binaltorphimine (nor-BNI), kappa opioid receptor antagonist (CAS 105618-26-6) (ab120078)
